Literature DB >> 21671075

The role of the TCF4 gene in the phenotype of individuals with 18q segmental deletions.

Minire Hasi1, Bridgette Soileau, Courtney Sebold, Annice Hill, Daniel E Hale, Louise O'Donnell, Jannine D Cody.   

Abstract

The goal of this study is to define the effects of TCF4 hemizygosity in the context of a larger segmental deletion of chromosome 18q. Our cohort included 37 individuals with deletions of 18q. Twenty-seven had deletions including TCF4 (TCF4 (+/-)); nine had deletions that did not include TCF4 (TCF4 (+/+)); and one individual had a microdeletion that included only the TCF4 gene. We compared phenotypic data from the participants' medical records, survey responses, and in-person evaluations. Features unique to the TCF4 (+/-) individuals included abnormal corpus callosum, short neck, small penis, accessory and wide-spaced nipples, broad or clubbed fingers, and sacral dimple. The developmental data revealed that TCF4 (+/+) individuals were only moderately developmentally delayed while TCF4 (+/-) individuals failed to reach developmental milestones beyond those typically acquired by 12 months of age. TCF4 hemizygosity also conferred an increased risk of early death principally due to aspiration-related complications. Hemizygosity for TCF4 confers a significant impact primarily with regard to cognitive and motor development, resulting in a very different prognosis for individuals hemizygous for TCF4 when compared to individuals hemizygous for other regions of distal 18q.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671075      PMCID: PMC3215814          DOI: 10.1007/s00439-011-1020-y

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  25 in total

1.  Deletion 18q21.2q21.32 involving TCF4 in a boy diagnosed by CGH-array.

Authors:  Joris Andrieux; Frédéric Lepretre; Jean-Marie Cuisset; Alice Goldenberg; Bruno Delobel; Sylvie Manouvrier-Hanu; Muriel Holder-Espinasse
Journal:  Eur J Med Genet       Date:  2008-01-14       Impact factor: 2.708

2.  Two percent of patients suspected of having Angelman syndrome have TCF4 mutations.

Authors:  K Takano; M Lyons; C Moyes; J Jones; C E Schwartz
Journal:  Clin Genet       Date:  2010-02-10       Impact factor: 4.438

3.  A syndrome of mental retardation, wide mouth and intermittent overbreathing.

Authors:  D Pitt; I Hopkins
Journal:  Aust Paediatr J       Date:  1978-09

Review 4.  Mental retardation, "coarse" face, and hyperbreathing: confirmation of the Pitt-Hopkins syndrome.

Authors:  I D Van Balkom; S Quartel; R C Hennekam
Journal:  Am J Med Genet       Date:  1998-01-23

5.  Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction.

Authors:  Jeanne Amiel; Marlene Rio; Loic de Pontual; Richard Redon; Valerie Malan; Nathalie Boddaert; Perrine Plouin; Nigel P Carter; Stanislas Lyonnet; Arnold Munnich; Laurence Colleaux
Journal:  Am J Hum Genet       Date:  2007-03-23       Impact factor: 11.025

6.  Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome).

Authors:  Christiane Zweier; Maarit M Peippo; Juliane Hoyer; Sergio Sousa; Armand Bottani; Jill Clayton-Smith; William Reardon; Jorge Saraiva; Alexandra Cabral; Ina Gohring; Koen Devriendt; Thomy de Ravel; Emilia K Bijlsma; Raoul C M Hennekam; Alfredo Orrico; Monika Cohen; Alexander Dreweke; Andre Reis; Peter Nurnberg; Anita Rauch
Journal:  Am J Hum Genet       Date:  2007-03-23       Impact factor: 11.025

7.  Severe mental retardation with breathing abnormalities (Pitt-Hopkins syndrome) is caused by haploinsufficiency of the neuronal bHLH transcription factor TCF4.

Authors:  Antje Brockschmidt; Unda Todt; Soojin Ryu; Alexander Hoischen; Christina Landwehr; Stefanie Birnbaum; Wilhelm Frenck; Bernhard Radlwimmer; Peter Lichter; Hartmut Engels; Wolfgang Driever; Christian Kubisch; Ruthild G Weber
Journal:  Hum Mol Genet       Date:  2007-05-03       Impact factor: 6.150

8.  Mental retardation, macrostomia and hyperpnoea syndrome.

Authors:  H A Singh
Journal:  J Paediatr Child Health       Date:  1993-04       Impact factor: 1.954

9.  CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy.

Authors:  J I Friedman; T Vrijenhoek; S Markx; I M Janssen; W A van der Vliet; B H W Faas; N V Knoers; W Cahn; R S Kahn; L Edelmann; K L Davis; J M Silverman; H G Brunner; A Geurts van Kessel; C Wijmenga; R A Ophoff; J A Veltman
Journal:  Mol Psychiatry       Date:  2007-07-24       Impact factor: 15.992

10.  Spatial and temporal specification of neural fates by transcription factor codes.

Authors:  François Guillemot
Journal:  Development       Date:  2007-09-26       Impact factor: 6.868

View more
  9 in total

Review 1.  Pitt-Hopkins Syndrome: A Review of Current Literature, Clinical Approach, and 23-Patient Case Series.

Authors:  Kimberly Goodspeed; Cassandra Newsom; Mary Ann Morris; Craig Powell; Patricia Evans; Sailaja Golla
Journal:  J Child Neurol       Date:  2018-01-10       Impact factor: 1.987

2.  Common Pathophysiology in Multiple Mouse Models of Pitt-Hopkins Syndrome.

Authors:  Courtney Thaxton; Alexander D Kloth; Ellen P Clark; Sheryl S Moy; Raymond A Chitwood; Benjamin D Philpot
Journal:  J Neurosci       Date:  2017-12-08       Impact factor: 6.167

3.  Pitt-Hopkins Syndrome.

Authors:  M Peippo; J Ignatius
Journal:  Mol Syndromol       Date:  2011-12-29

Review 4.  Evaluation of Nav1.8 as a therapeutic target for Pitt Hopkins Syndrome.

Authors:  Keri Martinowich; Debamitra Das; Srinidhi Rao Sripathy; Yishan Mai; Rakaia F Kenney; Brady J Maher
Journal:  Mol Psychiatry       Date:  2022-10-12       Impact factor: 13.437

5.  Establishing a reference group for distal 18q-: clinical description and molecular basis.

Authors:  Jannine D Cody; Minire Hasi; Bridgette Soileau; Patricia Heard; Erika Carter; Courtney Sebold; Louise O'Donnell; Brian Perry; Robert F Stratton; Daniel E Hale
Journal:  Hum Genet       Date:  2013-10-05       Impact factor: 4.132

6.  Case report of a novel phenotype in 18q deletion syndrome.

Authors:  Roxana Elena Bohîlţea; Monica Mihaela Cîrstoiu; Florina Mihaela Nedelea; Natalia Turcan; Tiberiu Augustin Georgescu; Octavian Munteanu; Alexandru Baroş; Anca Maria Istrate-Ofiţeru; Costin Berceanu
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

Review 7.  Pitt-Hopkins Syndrome: intellectual disability due to loss of TCF4-regulated gene transcription.

Authors:  J David Sweatt
Journal:  Exp Mol Med       Date:  2013-05-03       Impact factor: 8.718

8.  Behavioural and psychological characteristics in Pitt-Hopkins syndrome: a comparison with Angelman and Cornelia de Lange syndromes.

Authors:  Alice Watkins; Stacey Bissell; Jo Moss; Chris Oliver; Jill Clayton-Smith; Lorraine Haye; Mary Heald; Alice Welham
Journal:  J Neurodev Disord       Date:  2019-10-05       Impact factor: 4.025

9.  Two unrelated individuals carrying rare mosaic deletions in TCF4 gene.

Authors:  Ludmila Kousoulidou; Angelos Alexandrou; Ioannis Papaevripidou; Paola Evangelidou; George Tanteles; Violetta C Anastasiadou; Carolina Sismani
Journal:  Am J Med Genet A       Date:  2018-11-18       Impact factor: 2.802

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.